Welcome to LookChem.com Sign In|Join Free
  • or
Alverine Citrate Impurity C is a chemical compound associated with Alverine Citrate, a medication primarily used to treat muscle spasms and pain. As an impurity, it is a byproduct or contaminant that may be present in the manufacturing process of Alverine Citrate. The specific chemical structure and properties of Impurity C are not widely documented, but it is crucial to monitor and control the levels of such impurities to ensure the safety, efficacy, and quality of the final pharmaceutical product. Regulatory agencies like the FDA and EMA have guidelines for the acceptable levels of impurities in drugs, and pharmaceutical companies must adhere to these standards to maintain the integrity of their products.

13125-63-8

Post Buying Request

13125-63-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

13125-63-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 13125-63-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,1,2 and 5 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 13125-63:
(7*1)+(6*3)+(5*1)+(4*2)+(3*5)+(2*6)+(1*3)=68
68 % 10 = 8
So 13125-63-8 is a valid CAS Registry Number.

13125-63-8Relevant academic research and scientific papers

Method for preparing amine compound by reducing amide compound

-

Paragraph 0173-0175, (2021/02/10)

The invention relates to a method for preparing an amine compound by reducing an amide compound, which comprises the following steps: in a protective atmosphere, mixing the amide compound or cyclic amide, a zirconium metal catalyst and pinacol borane, carrying out amide reduction reaction at room temperature, and carrying out aftertreatment by using an ether solution of hydrogen chloride after 12-48 hours to obtain an amine hydrochloride compound. The method is simple to operate, low in cost, good in functional group tolerance and wide in substrate range.

Hydrosilylative reduction of primary amides to primary amines catalyzed by a terminal [Ni-OH] complex

Bera, Jitendra K.,Pandey, Pragati

supporting information, p. 9204 - 9207 (2021/09/20)

A terminal [Ni-OH] complex1, supported by triflamide-functionalized NHC ligands, catalyzes the hydrosilylative reduction of a range of primary amides into primary amines in good to excellent yields under base-free conditions with key functional group tolerance. Catalyst1is also effective for the reduction of a variety of tertiary and secondary amides. In contrast to literature reports, the reactivity of1towards amide reduction follows an inverse trend,i.e., 1° amide > 3° amide > 2° amide. The reaction does not follow a usual dehydration pathway.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 13125-63-8